03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
The U.S. Department of Labor’s Employee Benefits Security Administration (EBSA) released its progra...
Read More >
To provide another opportunity to receive input on the Agency’s proposed revisions to the EEO-1 rep...
Read More >
On July 9, 2019, the California Senate Judiciary Committee passed Assembly Bill 25 (AB 25), but only...
Read More >
Many markets, including the private credit markets, are facing market declines, disruptions and disl...
Read More >
The Ohio Eighth District Court of Appeals reversed enforcement of an employment arbitration agreemen...
Read More >
What’s happening at McDonald’s should serve as an important lesson for many employers. In the pas...
Read More >